Showing results (1381-1390 of 1,611) with videos related to

Sort By:
Pageof 162
Vaccine|March 2, 2010
The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunizationOlga V Masalova, Ekaterina I Lesnova, Alexei V Pichugin, et al.
Journal of Proteome Research|September 1, 2020
Proteome-Wide Analysis of ADAR-Mediated Messenger RNA Editing during Fruit Fly OntogenyAnna A Kliuchnikova, Anton O Goncharov, Lev I Levitsky, et al.
Stem Cell Research & Therapy|November 10, 2024
Management of radiation-induced proctitis using submucosal endoscopic injections of autologous adipose-derived stromal vascular fraction: a case reportA V Smirnov, V I Sychev, S M Kuznetsova, et al.
International Journal of Molecular Sciences|December 11, 2022
Biological Age Predictors: The Status Quo and Future TrendsVeronika V Erema, Anna Y Yakovchik, Daria A Kashtanova, et al.
Toxicology Research|August 10, 2018
Comparative effects of a candidate modified-risk tobacco product Aerosol and cigarette smoke on human organotypic small airway cultures: a systems toxicology approachAnita R Iskandar, Yannick Martinez, Florian Martin, et al.
Bioorganic & Medicinal Chemistry|January 30, 2013
N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptaseMikhail S Novikov, Vladimir T Valuev-Elliston, Denis A Babkov, et al.
ACS Nano|January 8, 2014
Rapid optimization of metal nanoparticle surface modification with high-throughput gel electrophoresisAlexander V Beskorovaynyy, Dmitry S Kopitsyn, Andrei A Novikov, et al.
Scientific Reports|May 11, 2018
Insight into the performance of multi-color InGaN/GaN nanorod light emitting diodesY Robin, S Y Bae, T V Shubina, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 12, 2020
Respiratory Effects of Exposure to Aerosol From the Candidate Modified-Risk Tobacco Product THS 2.2 in an 18-Month Systems Toxicology Study With A/J MiceBjoern Titz, Alain Sewer, Karsta Luettich, et al.
Pageof 162